These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 1831495

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study.
    Omura GA, Bundy BN, Berek JS, Curry S, Delgado G, Mortel R.
    J Clin Oncol; 1989 Apr; 7(4):457-65. PubMed ID: 2926470
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ, Lele SB.
    Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
    [Abstract] [Full Text] [Related]

  • 10. Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide.
    Colozza M, Mosconi AM, Gori S, Belsanti V, Basurto C, De Angelis V, Giansanti M, Tonato M.
    Am J Clin Oncol; 1997 Oct; 20(5):522-6. PubMed ID: 9345342
    [Abstract] [Full Text] [Related]

  • 11. Randomised comparison of cisplatin with cyclophosphamide/cisplatin and with cyclophosphamide/doxorubicin/cisplatin in advanced ovarian cancer. Gruppo Interegionale Cooperativo Oncologico Ginecologia.
    Lancet; 1987 Aug 15; 2(8555):353-9. PubMed ID: 2886821
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A comparison of hexamethylmelamine (altretamine), cyclophosphamide, doxorubicin, and cisplatin (H-CAP) vs. cyclophosphamide, doxorubicin, and cisplatin (CAP) in advanced ovarian cancer.
    Greco FA, Johnson DH, Hainsworth JD.
    Cancer Treat Rev; 1991 Mar 15; 18 Suppl A():47-55. PubMed ID: 1904309
    [Abstract] [Full Text] [Related]

  • 15. Importance of multiagent chemotherapy regimens in ovarian carcinoma: dose intensity analysis.
    Levin L, Simon R, Hryniuk W.
    J Natl Cancer Inst; 1993 Nov 03; 85(21):1732-42. PubMed ID: 8411257
    [Abstract] [Full Text] [Related]

  • 16. Randomised trial comparing combinations of cyclophosphamide and cisplatin without or with doxorubicin or 4'-epi-doxorubicin in the treatment of advanced ovarian cancer.
    Hernádi Z, Juhász B, Póka R, Lampé LG.
    Int J Gynaecol Obstet; 1988 Oct 03; 27(2):199-204. PubMed ID: 2903085
    [Abstract] [Full Text] [Related]

  • 17. A randomized study of cyclophosphamide and cis-platinum with or without doxorubicin in advanced ovarian carcinoma.
    Bertelsen K, Jakobsen A, Andersen JE, Ahrons S, Pedersen PH, Kiaer H, Arffmann E, Bichel P, Boestofte E, Strøyer I.
    Gynecol Oncol; 1987 Oct 03; 28(2):161-9. PubMed ID: 3311924
    [Abstract] [Full Text] [Related]

  • 18. ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer. ICON Collaborators. International Collaborative Ovarian Neoplasm Study.
    Lancet; 1998 Nov 14; 352(9140):1571-6. PubMed ID: 9843101
    [Abstract] [Full Text] [Related]

  • 19. A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.
    Conte PF, Bruzzone M, Chiara S, Sertoli MR, Daga MG, Rubagotti A, Conio A, Ruvolo M, Rosso R, Santi L.
    J Clin Oncol; 1986 Jun 14; 4(6):965-71. PubMed ID: 3519886
    [Abstract] [Full Text] [Related]

  • 20. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
    Harper P.
    Semin Oncol; 1997 Oct 14; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.